Pediatric Nephrology

, Volume 9, Issue 5, pp 579–582 | Cite as

Renal function following unilateral nephrectomy for neuroblastoma and Wilms' tumour

  • Matthias Schell
  • Pierre Cochat
  • Aoumeur Hadj-Aïssa
  • Eric Bouffet
  • Laurence Dubourg
  • Maud Brunat-Mentigny
Original Article

Abstract

To estimate the side effects of chemotherapy and the influence of age at the time of nephrectomy on renal function, we investigated renal function in 34 uninephrectomised children with neuroblastoma (NB) or Wilms' tumour (WT). The results were compared with 6 controls who underwent nephrectomy for non-malignant disease. Study of renal function was primarily based on the clearance of inulin and para-aminohippuric acid (Cin andCPAH, ml/min per 1.73 m2). No significant differences inCin/CPAH (mean±SD) were found between the NB group (90±24/421±95), WT group (85±17/386±104) and the controls (93±13/430±61). Children with NB and WT were divided into two subgroups according to the theoretical nephrotoxic risk. There was no significant difference in renal function between NB or between WT subgroups. Cumulative cisplain doses in children with NB did not affect renal function significantly. The age at time of unilateral nephrectomy (≤2 years vs. ≥2 years) was not associated with a higher risk of renal damage in WT children, whereas in NB children the filtration fraction (Cin:CPAH) was higher in younger children (mean±SD: 0.243±0.023 vs. 0.191±0.041). In conclusion, uninephrectomised children with NB are supposed to have a higher risk of drug-induced renal impairment compared with those with WT. Our data do not confirm this hypothesis, since renal function was comparable to controls in both groups, except in younger patients with NB who show a high filtration fraction. Since the survival of children with NB has improved, a longer follow-up of their renal function in needed.

Key words

Drug-induced renal impairment Neuroblastoma Nephroblastoma Glomerular filtration rate Uninephrectomy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fotino S (1989) The solitary kidney: a model of chronic hyperfiltration in humans. Am J Kidney Dis 13: 88–98PubMedGoogle Scholar
  2. 2.
    Simon J, Zamora I, Mendizabal S, Castel V, Lurbe A (1982) Glomerulotubular balance and functional compensation in nephrectomized children. Nephron 31: 203–208PubMedGoogle Scholar
  3. 3.
    Robitaille P, Mongeau JG, Lortie L, Sinnassamy P (1985) Long-term follow-up of patients who underwent unilateral nephrectomy in childhood. Lancet 1: 1297–1299PubMedGoogle Scholar
  4. 4.
    Wikstad I, Pettersson BA, Elinder G, Sökücü S, Aperia A (1986) A comparative study of size and function of the remnant kidney in patients nephrectomized in childhood for Wilms' tumor and hydronephrosis. Acta Paediatr Scand 75: 408–414PubMedGoogle Scholar
  5. 5.
    Burk CD, Restaino I, Kaplan BS, Meadows AT (1990) Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor. J Pediatr 117: 331–335PubMedGoogle Scholar
  6. 6.
    Tournade MF (1989) A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor. Cancer Chemother Pharmacol 24: 31–33Google Scholar
  7. 7.
    Womer RB, Pritchard J, Barratt TM (1985) Renal toxicity of cisplatin in children. J Pediatr 106: 659–663PubMedGoogle Scholar
  8. 8.
    Barrera M, Roy LP, Stevens M (1989) Long-term follow-up after unilateral nephrectomy and radiotherapy for Wilms' tumour. Pediatr Nephrol 3: 430–432PubMedGoogle Scholar
  9. 9.
    Bhisitkul DM, Morgan ER, Vozar MA, Langman CB (1990) Renal functional reserve in long-term survivors of unilateral Wilms tumor. J Pediatr 118: 698–702Google Scholar
  10. 10.
    Brillet G, Deray G, Bunker D, Hmida MB, Baumelou A, Jacobs C (1991) Peut-on prévenir la toxicité rénale du cisplatine? Néphrologie 12: 143–146Google Scholar
  11. 11.
    Brock P, Koliouskas DE, Barratt TM, Yeomans L, Pritchard J (1991) Partial reversibility of cisplatin nephrotoxicity in children. J Pediatr 118: 531–534PubMedGoogle Scholar
  12. 12.
    Goren MP, Wright RK, Horowitz ME (1986) Cumulative renal tubular damage associated with cisplatin nephrotoxicity. Cancer Chemother Pharmacol 18: 69–73PubMedGoogle Scholar
  13. 13.
    Highley M, Meller ST, Pinkerton CR (1992) Seizures and cortical dysfunction following high-dose cisplatin administration in children. Med Pediatr Oncol 20: 143–148PubMedGoogle Scholar
  14. 14.
    Skinner R, Pearson ADJ, Coulthard MG, Skillen AW, Hodson AW, Goldfinch ME, Gibb I, Craft AW (1991) Assessment of chemotherapy-associated nephrotoxicity in children with cancer. Cancer Chemother Pharmacol 28: 81–92PubMedGoogle Scholar
  15. 15.
    Skinner R, Pearson ADJ, Price L, Coulthard MG, Craft AW (1990) Nephrotoxicity after ifosfamide. Arch Dis Child 65: 732–738PubMedGoogle Scholar
  16. 16.
    Suarez A, McDowell H, Niaudet P, Comoy E, Flamant F (1991) Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report. J Clin Oncol 9: 2177–2182PubMedGoogle Scholar
  17. 17.
    Brade WP, Herdrich K, Kachel-Fischer U, Araujo CE (1991) Dosing and side-effects of ifosfamide plus mesna. J Cancer Res Clin Oncol 117: 164–186Google Scholar
  18. 18.
    Sleijfer DT, Smit EF, Meijer S, Mulder NH, Postmus PE (1989) Acute and cumulative effects of carboplatin on renal function. Br J Cancer 60: 116–120PubMedGoogle Scholar
  19. 19.
    Bergstein J, Andreoli SP, Provisor AJ, Yum M (1986) Radiation nephritis following total-body irradiation and cyclophosphamide in preparation for bone marrow transplantation. Transplantation 41: 63–66PubMedGoogle Scholar
  20. 20.
    Zager RA, O'Quigley J, Zager BK, Alpers CE, Shulman HM, Gamelin LM, Steward P, Thomas ED (1989) Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 8: 210–216Google Scholar
  21. 21.
    Freycon MT, Lavocat MP, Frappaz D (1990) Néphrotoxicité des antimitotiques. Pédiatrie 45: 37s-44sGoogle Scholar
  22. 22.
    Tournade MF, Com-Nougvé C, Voûte PA, Lemerle J, de Kraker J, Delemarre JFM, Burgers M, Habrand JL, Moorman CGM, Bürger D, Rey A, Zucker JM, Carli M, Jereb B, Bey P, Gauthier F, Sandstedt B. Results of the Sixth International Society of Pediatric Oncology Wilm's Tumor Trial and Study: a risk-adapted therapeutic approach in Wilm's tumor. J Clin Oncol (1993) 11: 1014–1023PubMedGoogle Scholar
  23. 23.
    Nephroblastoma clinical trial. SIOP no. 9, protocol, December 1987Google Scholar
  24. 24.
    Larsson L, Aperia A, Wilton P (1980) Effect of normal development on compensatory renal growth. Kidney Int 18: 29–35PubMedGoogle Scholar
  25. 25.
    Schmitz A, Christensen CK, Christensen T, Solling K (1989) No microalbuminuria or other adverse effects of long-standing hyperfiltration in humans with one kidney. Am J Kidney Dis 13: 131–136PubMedGoogle Scholar
  26. 26.
    Donaldson SS, Moskowitz PS, Canty EL, Efron B (1978) Radiation-induced inhibition of compensatory renal growth in weanling mouse kidney. Radiology 128: 491–495PubMedGoogle Scholar
  27. 27.
    Moskowitz PS, Donaldson SS, Canty EL (1980) Chemotherapy-induced inhibition of compensatory renal growth in the immature mouse. Am J Radiol 134: 491–496Google Scholar
  28. 28.
    Daugaard G, Rossing N, Rorth M (1988) Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose. Cancer Chemother Pharmacol 21: 163–167PubMedGoogle Scholar
  29. 29.
    Brock P, Yeomans L, Pritchard J (1990) Cisplatin in infants (abstract). Cancer in the very young child, Leeds, 27–28 September 1990Google Scholar
  30. 30.
    Kamalakar P, Freeman AI, Higby OJ, Wallace HJ Jr, Sinks LF (1977) Clinical response and toxicity withcis-dichlorodiammine platinum (II) in children. Cancer Treat Rep 61: 835PubMedGoogle Scholar
  31. 31.
    Jongejan HTM, Provoost AP, Wolff ED, Molenaar JC (1986) Nephrotoxicity of cisplatin comparing young and adult rats. Pediatr Res 20: 9PubMedGoogle Scholar
  32. 32.
    Hrushesky WJM, Shimp W, Kennedy BJ (1984) Lack of age-dependent cisplatin nephrotoxicity. Am J Med 76: 579–584PubMedGoogle Scholar
  33. 33.
    Skinner R, Pearson ADJ, Price L, Coulthard MG, Craft AW (1989) Nephrotoxicity of ifosfamide in children. Lancet II: 159Google Scholar

Copyright information

© IPNA 1995

Authors and Affiliations

  • Matthias Schell
    • 1
    • 4
  • Pierre Cochat
    • 1
  • Aoumeur Hadj-Aïssa
    • 2
  • Eric Bouffet
    • 3
  • Laurence Dubourg
    • 1
    • 2
  • Maud Brunat-Mentigny
    • 3
  1. 1.Unité de Néphrologie PédiatriqueHôpital Edouard HerriotLyon Cedex 03France
  2. 2.Service d'Exploration Fonctionnelle RénaleHôpital Edouard Herriot et Université Claude BernardLyon Cedex 03France
  3. 3.Service de PédiatrieCentre Léon BérardLyonFrance
  4. 4.Abteilung II der Universitäts-KinderklinikTübingenGermany

Personalised recommendations